NysnoBio helps patients with medical conditions develop the Parkin protein's therapeutic potential.
NysnoBio has raised $2.5M in total funding. The most recent round was Grant. The last funding was announced in January 2025.
NysnoBio's investors include Michael J. Fox Foundation, California Institute for Regenerative Medicine.
NysnoBio is headquartered in Mill Valley, United States.
NysnoBio helps patients with medical conditions develop the Parkin protein's therapeutic potential.
NysnoBio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NysnoBio — Funding & Investors." VCBacked, January 30, 2025, https://www.vcbacked.co/company/nysnobio. Accessed August 16, 2026.
VCBacked. (2025). NysnoBio — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/nysnobio
{{cite web |title=NysnoBio — Funding & Investors |url=https://www.vcbacked.co/company/nysnobio |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated